Asia Pacific Nootropics Market Size & Outlook, 2021-2030
Asia Pacific nootropics market, 2018-2030 (US$M)
Related Markets
Asia Pacific nootropics market highlights
- The Asia Pacific nootropics market generated a revenue of USD 945.7 million in 2021.
- The market is expected to grow at a CAGR of 15.5% from 2022 to 2030.
- In terms of segment, capsules/tablets was the largest revenue generating form in 2021.
- Drinks is the most lucrative form segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2022 to 2030.
Asia Pacific data book summary
| Market revenue in 2021 | USD 945.7 million |
| Market revenue in 2030 | USD 3,460.0 million |
| Growth rate | 15.5% (CAGR from 2021 to 2030) |
| Largest segment | Capsules/tablets |
| Fastest growing segment | Drinks |
| Historical data covered | 2018 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Capsules/Tablets, Powder, Drinks |
| Key market players worldwide | Reckitt Benckiser Group PLC, Mental Mojo, Noocube, Mind Lab, truBrain, Nooflux, Zhou Nutrition, Kimera Koffee |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 28.4% of the global nootropics market in 2021.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,460.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nootropics Market Scope
Nootropics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific nootropics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nootropics market will help companies and investors design strategic landscapes.
Capsules/tablets was the largest segment with a revenue share of 49.52% in 2021. Horizon Databook has segmented the Asia Pacific nootropics market based on capsules/tablets, powder, drinks covering the revenue growth of each sub-segment from 2018 to 2030.
Growing awareness of daily nutritional requirements has driven consumer demand for certain medical supplements, including functional and nootropics, especially in response to the COVID-19 pandemic in Asia Pacific.
With people unable to fulfill their nutritional requirements through standard diets, they are recognizing the importance of additional dietary supplements such as vitamins, minerals, nootropics, and others.
Increasing demand for sports supplements comprising nootropics on account of their ascending consumption by athletes to improve attention and focus is expected to fuel market growth.
Reasons to subscribe to Asia Pacific nootropics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific nootropics market databook
-
Our clientele includes a mix of nootropics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific nootropics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific nootropics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific nootropics market size, by country, 2018-2030 (US$M)
Asia Pacific Nootropics Market Outlook Share, 2021 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
